Vitasynth sp. z o.o.

Manufacture of basic pharmaceutical products

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2009-11-06
Share capital
5,000.00 PLN
Registered address
ul. Macieja Rataja 4G, 05-850 Koprki, Poland
Email
Phone
Electronic delivery address
AE:PL-40417-59630-WAIDW-37

Financials

Revenue history (in k)

From the notes

Current income tax (CIT due)$2,413

Filing timeliness

4 of 6 financial statements were filed late (the longest delay 147 days for 2021).

  • 202502/10/2026
  • 202414/08/2025
  • 202328/03/2024
  • 202212/07/2023
  • 202109/12/2022
  • 202021/10/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Sector · Manufacturing5,076 / 24,570
Top 21%
Voivodeship · Mazowieckie6,655 / 76,953
Top 8.7%
Country · Poland24,561 / 297,266
Top 8.3%

Results vs industry

Revenue
This companyUSD 7.39mMedianUSD 165.97kAverageUSD 2.30m
Net profit
This companyUSD 2.39mMedianUSD 1.32kAverageUSD 109.80k
Operating costs
This companyUSD 4.74mMedianUSD 201.81kAverageUSD 2.10m
Assets
This companyUSD 10.14mMedianUSD 118.27kAverageUSD 1.54m

Offer

Certifications: GMP, HACCP

Websites

  • pharmaquinone.comPharmaquinone - Vitamin K2 Revolution - Supplier, Manufacturer
    WebflowGoogle AdsGoogle AnalyticsGoogle Tag ManagerCloudflare

Authorized Representatives

Piotr Wodzisław Jandziak age 48 – President of the Management Board

Manner of representation

The company is represented by the President of the Management Board independently or by two members of the management board acting jointly.

Ownership

OwnerSharesShare valueStake
10$135.0610%
90$1,215.5690%

Piotr Wodzisław Jandziak and Marianna Małgorzata Jandziak hold a combined 100% – the ownership structure indicates family control.

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2010-03-01.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

11 public aid cases recorded, with a total value of $901,559.

PurposeGross amount
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
–
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
–
Regional investment aid
–

European Funds

4 projects co-financed from European Funds recorded, with total EU co-financing of $868,991.

ProjectEU co-financing
Implementation of R&D work on an innovative chemical synthesis technology for vitamin K2 (MK-7).
$132.9K
Using the results of completed R&D work as an opportunity to increase the Company's competitiveness on the international market
$275.9K
Development of a technology for producing vitamin K2 based on biosynthesis and organic synthesis mechanisms by Vitasynth sp. z o.o.
$327.7K

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Competitors

Name
Exim Pharma sp. z o.o.
Laboratoria Natury sp. z o.o.
Panawit sp. z o.o.
Medicofarma S.A.
Wellmedica Hf sp. z o.o.
Eubiosis sp. z o.o.
Wegafarm Plucińscy sp. k.
Pharmacreator sp. z o.o.
Nikalab sp. z o.o.
Bioactive T sp. z o.o.

Change history

DateEvent
2024-10-10Address change
2020-11-30Address change
2017-01-04Address change
2017-01-04PKD change
2016-07-04Address change

FAQ

Last updated: 2026-10-07